Has Jefferson Moulds, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,576 in general payments to Jefferson Moulds, MD across 133 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jefferson Moulds, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jefferson Moulds, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jefferson Moulds, MD

Radiation Oncology · Onancock, VANPI 1265420582

Payments from drug & device makers

$3,576in general payments, 2019–2025

Across 133 payments — averaging $26.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Daiichi Sankyo Inc.$344
Novartis$325
AstraZeneca$261
Merck$234
Johnson & Johnson$229
AVEO Pharmaceuticals, Inc.$159
plus $2K from 44 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Daiichi Sankyo Inc.	8	$344
Novartis	15	$325
AstraZeneca	7	$261
Merck	11	$234
Johnson & Johnson(2 entities)	9	$229
AVEO Pharmaceuticals, Inc.	5	$159
Regeneron Healthcare Solutions, Inc.	7	$134
Myriad Genetic Laboratories, Inc.	1	$123
Bayer	4	$106
Pharmaessentia USA Corporation	4	$104
Progenics Pharmaceuticals, Inc.	1	$100
Lilly USA, LLC	4	$97
Eisai Inc.	4	$87
Foundation Medicine, Inc.	1	$78
Incyte Corporation	4	$77
Beigene USA, Inc.	2	$67
AbbVie	2	$63
Ipsen Biopharmaceuticals, Inc	2	$58
Takeda Pharmaceuticals U.S.A., Inc.	2	$51
Exelixis Inc.	2	$48
Dendreon Pharmaceuticals LLC	2	$48
ADC Therapeutics America, Inc.	2	$46
Sobi, Inc	2	$42
Genentech USA, Inc.	2	$41
Boston Scientific	1	$41
Mirati Therapeutics, Inc.	1	$40
Puma Biotechnology, Inc.	2	$39
Seagen Inc.	2	$37
Genmab U.S., Inc.	1	$35
GSK	1	$34
Sumitomo Pharma America, Inc.	2	$32
Alnylam Pharmaceuticals Inc.	2	$26
Karyopharm Therapeutics Inc.	1	$26
Immunogen, Inc.	1	$25
Blueprint Medicines Corporation	1	$25
Sanofi	1	$25
Spectrum Pharmaceuticals Inc.	1	$23
Agios Pharmaceuticals, Inc.	1	$23
Pharmacosmos Therapeutics Inc.	1	$22
E.r. Squibb & Sons, L.L.C.	1	$22
Astellas Pharma US Inc	1	$21
Pfizer	1	$20
Shield Therapeutics Inc	1	$20
Amgen	1	$19
EMD Serono, Inc.	1	$18
Array Biopharma Inc	1	$18
Siemens Medical Solutions USA, Inc.	1	$17
Acrotech Biopharma Inc.	1	$17
Recordati_rare_diseases_inc.	1	$16
Deciphera Pharmaceuticals Inc.	1	$14

How this compares

$3,576 in reported general payments places this provider in the 80th percentile of 121 radiation oncology providers in Virginia.

See all radiation oncology providers in Virginia →

Medicare billing

Part B allowed, 2024

$864,202

Medicare patients

129

Services billed

3,325

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Onancock

David BuckRoanoke$2.9M
Daniel KimFairfax$433K
James LarnerCharlottesville$294K
Gregory SibleyFairfax$236K
Timothy ShowalterCharlottesville$106K
Samir KananiFairfax$90K
David PenberthyCharlottesville$67K
Susan BoylanWoodbridge$58K
Shiyu SongRichmond$55K
Elisabeth WeissRichmond$48K

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →